DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Pennisi A, Li X, Ling W. et al.
The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo.
Am J Hematol 2009; 84 (1): 6-14
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.